(Press-News.org) Researchers at University of California San Diego found that cigarette smoking continues to decline across the United States, largely driven by young adults. Their study, published in JAMA Network Open on April 25, 2025, reveals that the states with historically high smoking rates have seen the most dramatic declines. However, smoking cessation progress among adults over 50 has been much slower, which could prolong the public health burden of smoking-related diseases and death.
“The rapid decline in smoking among young adults is clear evidence that the smoking epidemic will come to an end in our lifetime,” said Matthew Stone, Ph.D., first author and assistant professor at the UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science and Moores Cancer Center member. “Indeed, we project that the national smoking prevalence will be under 5% by 2035. However, the much slower decline in smokers over the age of 50, particularly in previously high smoking states, will mean that the high rates of lung cancer, heart disease and chronic obstructive pulmonary disease that are caused by lifelong smoking will take longer to decrease.”
Researchers used the publicly available Tobacco Use Supplements to the U.S. Census Bureau’s Current Population Survey. The survey is a large — approximately 54,000 households — monthly representative survey that provides information on employment and economic well-being. For this study, all analyses were conducted between June and October 2024. A total of 1.77 million respondents were analyzed.
The study found:
Large differences in smoking prevalence existed across U.S. states in both the 1990s and in 2022, when the study authors obtained smoking prevalence estimates. The most significant decline in smoking happened in states with historically high smoking rates.
Differences in prevalence across age, sex, race and ethnicity, and education persisted across the years. There was a larger decline in young adult smoking compared with other states with lower historical rates of smoking. However, the gain was offset by a much slower decline among adults 50 and older.
Since the 1950s, when researchers first linked smoking to lung cancer, national smoking rates have dropped dramatically. In 1955, 56.9% of U.S. adults smoked. By the turn of the century, that figure had fallen by more than half, and by 2022, it had dropped again by 50%. The trend is expected to continue, with smoking rates projected to halve again by 2035. Recent evidence indicates that states that have made the greatest progress in reducing smoking have also seen the largest declines in lung cancer mortality — typically with a 16-year lag.
“While the ongoing decline in cigarette smoking is a major public health success story,” said John P. Pierce, Ph.D., corresponding author and Distinguished Professor at the Herbert Wertheim School of Public Health and Human Longevity Science and Moores Cancer Center. “Recent evidence suggests that the tobacco industry has successfully recruited a new generation of teenagers into e-cigarette use and nicotine addiction. Further research is needed to assess the long-term impact of this shift.”
# # #
Additional co-authors on the study include: Brian Dang, M.S., Sara B. McMenamin, Ph.D., David R. Strong, Ph.D., Yuyan Shi, Ph.D., Karen Messer, Ph.D., and Dennis R. Trinidad, Ph.D., at UC San Diego; Candice D. Donaldson, Ph.D., and Xueying Zhang, M.D., from the Tobacco Control Branch, California Department of Public Health (CDPH).
The study was funded, in part, by the Tobacco-Related Disease Research Program (TRDRP) of the University of California Office of the President (Nos. T31Ir-1584 and T32IR-4988) and CDPH (No. 22-10341.)
# # #
END
Young adults drive historic decline in smoking
Despite gains, slower decline among adults over 50 may delay reductions in smoking-related deaths
2025-04-25
ELSE PRESS RELEASES FROM THIS DATE:
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
2025-04-25
NFCR Congratulates Dr. Robert C. Bast, Jr. on Receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Rockville, MD — The National Foundation for Cancer Research (NFCR) proudly congratulates Dr. Robert C. Bast, Jr., a pioneering cancer scientist, and NFCR-supported investigator from 2001 to 2018, on being named the 2025 recipient of the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research.
Presented by the American Association for Cancer Research (AACR), ...
Chimpanzee stem cells offer new insights into early embryonic development
2025-04-25
Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and developmental biology. Pluripotent stem cells (PSCs) have been invaluable tools in this field, as they can transform into various cell types in the body and play key roles during early embryonic development. Unfortunately, research on this topic in humans and other primates has long been hampered by ethical constraints and technical limitations.
Of particular interest are naive-type PSCs, which represent an earlier developmental state than conventional (or ‘primed’) PSCs and possess enhanced differentiation potential. While human naive PSCs can differentiate ...
This injected protein-like polymer helps tissues heal after a heart attack
2025-04-25
Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure.
The therapy both prompts the immune system to encourage tissue repair and promotes survival of heart muscle cells after a heart attack. Researchers tested the therapy in rats and showed that it is effective up to five weeks after injection.
The research team, led by bioengineers at the University of California San Diego and chemists at Northwestern University, published ...
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
2025-04-25
FlexTech, an international academic journal (ISSN 2771-1706), jointly published by Tsinghua University Press and Wiley Publishing Group, has officially released its first issue. Supported by Tsinghua University’s State Key Laboratory of Flexible Electronics Technology, the journal aims to serve as a global platform for scholars to advance cutting-edge research and engineering applications in flexible materials, devices, and systems, driving humanity toward an intelligent era.
Editor-in-Chief’s Vision: Bridging Humanity, Machines, and the Digital World
In his inaugural editorial, Prof. Xue Feng from Tsinghua University, Editor-in-Chief ...
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
2025-04-25
Studies by a growing number of labs have identified neurological health benefits from exposing human volunteers or animal models to light, sound and/or tactile stimulation at the brain’s “gamma” frequency rhythm of 40Hz. In the latest such research at The Picower Institute for Learning and Memory and Alana Down Syndrome Center at MIT, scientists found that 40Hz sensory stimulation improved cognition and circuit connectivity and encouraged the growth of new neurons in mice genetically engineered to model Down syndrome.
Li-Huei Tsai, Picower Professor at MIT and senior author of the new study in PLOS ONE, said that the results are encouraging but also cautioned ...
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
2025-04-25
Methyl eugenol (ME), a phenylpropanoid compound found in the essential oils of various aromatic plants, has recently garnered attention due to its significant antioxidant, anticancer, and neuroprotective properties. ME, commonly used in the fragrance and food industries, is also studied for its potential therapeutic effects, particularly in mitigating diseases associated with oxidative stress, such as Alzheimer’s disease, cancers, and ischemic brain injuries. However, despite its therapeutic promise, concerns ...
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
2025-04-25
A research article published by the Shanghai University presented a novel microfluidic chip design with a 3-layer configuration that utilizes a polycarbonate (PC) porous membrane to separate the culture fluid channels from the tissue chambers, featuring flexibly designable multitissue chambers. PC porous membranes act as the capillary in the vertical direction, enabling precise hydrogel patterning and successfully constructing a microfluidic environment suitable for microvascular tissue growth.
The new research paper, published on Feb. 28, 2025 in the journal Cyborg and Bionic Systems, presented a flexible and scalable chip that is highly suitable for culturing multiple ...
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
2025-04-25
A new study found that a gene recently recognized as a biomarker for Alzheimer’s disease is actually a cause of it, due to its previously unknown secondary function. Researchers at the University of California San Diego used artificial intelligence to help both unravel this mystery of Alzheimer’s disease and discover a potential treatment that obstructs the gene’s moonlighting role.
The research team published their results on April 23 in the journal Cell.
About one in nine people aged 65 ...
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
2025-04-25
Coalition of Autism Scientists Critiques U.S. Department of Health and Human Services Autism Research Initiative
Boston, MA, April 25, 2025 – The newly formed Coalition of Autism Scientists today issued a statement in response to remarks and actions taken by Robert F. Kennedy, Jr., Secretary of the U.S. Department of Health and Human Services (HHS) regarding the study of autism. Led by Helen Tager-Flusberg, Ph.D., Professor Emerita, Department of Psychological & Brain Sciences, Director of the Center for Autism Research, Boston University, this growing group of experienced research scientists from ...
Structure dictates effectiveness, safety in nanomedicine
2025-04-25
Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The specific location of each atom within the drug molecule is a critical factor in determining how well it works and how safe it is. In ibuprofen, for example, one molecule is effective as a pain reliever, but the mirror image of that same molecule is completely inactive.
Now, Northwestern University and Mass General Brigham scientists argue that this precise structural control, which is applied to traditional medicines, should be harnessed to usher in a new class of potent nanomedicines that can ...
LAST 30 PRESS RELEASES:
Research alert: Spreading drug costs over the year may ease financial burden for Medicare cancer patients
Hospital partnership improves follow up scans, decreases long term risk after aortic repair
Layered hydrogen silicane for safe, lightweight, and energy-efficient hydrogen carrier
Observing positronium beam as a quantum matter wave for the first time
IEEE study investigates the effects of pointing error on quantum key distribution systems
Analyzing submerged fault structures to predict future earthquakes in Türkiye
Quantum ‘alchemy’ made feasible with excitons
‘Revoice’ device gives stroke patients their voice back
USF-led study: AI helps reveal global surge in floating algae
New method predicts asthma attacks up to five years in advance
Researchers publish first ever structural engineering manual for bamboo
National poll: Less than half of parents say swearing is never OK for kids
Decades of suffering: Long-term mental health outcomes of Kurdish chemical gas attacks
Interactional dynamics of self-assessment and advice in peer reflection on microteaching
When aging affects the young: Revealing the weight of caregiving on teenagers
Can Canada’s health systems handle increased demand during FIFA World Cup?
Autistic and non-autistic faces may “speak a different language” when expressing emotion
No clear evidence that cannabis-based medicines relieve chronic nerve pain
Pioneering second-order nonlinear vibrational nanoscopy for interfacial molecular systems beyond the diffraction limit
Bottleneck in hydrogen distribution jeopardises billions in clean energy
Lung cancer death rates among women in Europe are finally levelling off
Scientists trace microplastics in fertilizer from fields to the beach
The Lancet Obstetrics, Gynecology, & Women’s Health: Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities, confirms new gold-standard evidence review
Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities
Harm reduction vending machines in New York State expand access to overdose treatment and drug test strips, UB studies confirm
University of Phoenix releases white paper on Credit for Prior Learning as a catalyst for internal mobility and retention
Canada losing track of salmon health as climate and industrial threats mount
Molecular sieve-confined Pt-FeOx catalysts achieve highly efficient reversible hydrogen cycle of methylcyclohexane-toluene
Investment in farm productivity tools key to reducing greenhouse gas
New review highlights electrochemical pathways to recover uranium from wastewater and seawater
[Press-News.org] Young adults drive historic decline in smokingDespite gains, slower decline among adults over 50 may delay reductions in smoking-related deaths